or Try an Advanced Search...

    Liver Disease Stocks List

    Symbol Grade Name % Change
    GNFT C GENFIT S.A. 0.26
    BLTE C Belite Bio, Inc. -0.16
    GALT C Galectin Therapeutics Inc. 2.61
    TARA D ArTara Therapeutics, Inc. 0.81
    ALNY D Alnylam Pharmaceuticals, Inc. 2.59
    NTLA D Intellia Therapeutics, Inc. -0.19
    GYRE F Gyre Therapeutics, Inc. -2.18
    GILD F Gilead Sciences, Inc. 1.27
    MIRM F Mirum Pharmaceuticals, Inc. -0.96
    ALGS F Aligos Therapeutics, Inc. -3.55
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
    Related Stock Lists: Hepatitis Medicine Non Alcoholic Fatty Liver Disease Steatohepatitis Biopharmaceutical Alcohol Hepatology Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Clinical Medicine Coronavirus Drug Development Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Transthyretin

    Related ETFs - A few ETFs which own one or more of the above listed Liver Disease stocks.

    Symbol Grade Name Weight
    IBB B iShares Nasdaq Biotechnology Index Fund 9.83
    IBBQ B Invesco Nasdaq Biotechnology ETF 9.79
    BBH B Market Vectors Biotech ETF 9.28
    BIS F ProShares UltraShort Nasdaq Biotechnology 9.01
    GNOM D Global X Genomics & Biotechnology ETF 8.06
    View all Liver Disease ETFs...
    Compare ETFs
    Compare IBB to BBH Compare IBB to BIS Compare IBB to IBBQ

        Liver Disease Stocks Recent News

        Date Stock Title
        May 15 GILD Gilead Sciences, Inc. (GILD) RBC Capital Markets Global Healthcare Conference (Transcript)
        May 15 GALT Galectin Therapeutics GAAP EPS of -$0.19
        May 15 GALT Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2024 and Provides Business Update
        May 15 BLTE Belite Bio, Inc 2024 Q1 - Results - Earnings Call Presentation
        May 15 BLTE Belite Bio, Inc (BLTE) Q1 2024 Earnings Call Transcript
        May 14 BLTE Belite Bio reports Q1 results
        May 14 GILD Gilead Sciences, Inc. (GILD) BofA Securities 2024 Health Care Conference (Transcript)
        May 14 GILD Kite Data at EHA 2024 Demonstrate Positive Patient Outcomes and Advances in Delivery of CAR T-cell Therapy
        May 14 NTLA Intellia Therapeutics, Inc. (NTLA) Just Overtook the 50-Day Moving Average
        May 14 GILD Gilead Sciences: Native Health Navigator Program Connects Tribes to Cancer Care
        May 14 BLTE Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
        May 14 BLTE Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
        May 13 GILD One stock is dragging down the S&P 500's earnings growth
        May 13 MIRM Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2024 Earnings Call Transcript
        May 13 BLTE Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
        May 13 GALT Galectin Therapeutics to Participate in the H.C. Wainwright BioConnect Conference
        May 13 NTLA Intellia Therapeutics: 3 Near-Term Pivotal In Vivo Gene Therapies
        May 12 NTLA Earnings Beat: Intellia Therapeutics, Inc. (NASDAQ:NTLA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
        May 11 MIRM Mirum Pharmaceuticals, Inc. (MIRM) Q1 2024 Earnings Call Transcript
        May 11 GYRE Gyre Therapeutics Reports First Quarter 2024 Earnings
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Information Services
        Related Stock Lists: Hepatitis Medicine Non Alcoholic Fatty Liver Disease Steatohepatitis Biopharmaceutical Alcohol Hepatology Amyloid Amyloidosis Antitrypsin Deficiency Biotechnology Clinical Medicine Coronavirus Drug Development Hepatitis B Liver Liver Fibrosis Primary Biliary Cholangitis Pulmonary Arterial Hypertension Transthyretin
        Liver Disease

        Liver disease (also called hepatic disease) is a type of damage to or disease of the liver. Whenever the course of the problem lasts long, chronic liver disease ensues.

        More about Liver Disease
        Browse All Tags